Assurex Health, a US-based neuropsychiatric personalised medicine company, has raised $7m from investors including two hospital groups, on top of $25m of debt.
Mayo Clinic and Cincinnati Children’s Hospital Medical Center provided the equity along with Ohio State’s venture investment group CincyTech and venture capital firms Sequoia Capital, Claremont Creek Ventures, Allos Ventures, Four Rivers Partners, Danmar Capital and JVen Capital.
Assurex’s investors had previously supported an $11m series B round in March 2011 and a $12.5m series C round in May 2012.
Silicon Valley Bank and GE Capital, Healthcare Financial Services provided the $25m term and revolving credit facility. SVB previously supplied $8m in debt financing to Assurex in January 2012.
Assurex Health has also licensed patented technology from Mayo Clinic and Cincinnati Children’s Hospital to support its GeneSight products, which measures individual responses to behavioural health medications.